BioRegenx Reports Officer and Director Changes
Ticker: BRGX · Form: 8-K · Filed: Apr 14, 2025 · CIK: 1593184
| Field | Detail |
|---|---|
| Company | Bioregenx, INC. (BRGX) |
| Form Type | 8-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance, officer-appointment, director-election
TL;DR
BioRegenx shakes up its board and exec team, effective April 4th.
AI Summary
BioRegenx, Inc. filed an 8-K on April 14, 2025, reporting changes effective April 4, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved, their roles, and the nature of the compensatory arrangements are not provided in this excerpt.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, operational focus, or governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future strategy and execution, warranting closer monitoring.
Key Players & Entities
- BIOREGENX, INC. (company) — Registrant
- April 4, 2025 (date) — Effective date of reported events
- April 14, 2025 (date) — Filing date of the 8-K report
- Nevada (jurisdiction) — State of incorporation
- FINDIT, INC. (company) — Former company name
- ARTEMIS ENERGY HOLDINGS, INC. (company) — Former company name
FAQ
What specific changes were made regarding directors and officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, effective April 4, 2025. Specific names and roles are not detailed in this excerpt.
What is the effective date of the reported changes?
The earliest event reported has an effective date of April 4, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on April 14, 2025.
What is BioRegenx, Inc.'s state of incorporation?
BioRegenx, Inc. is incorporated in Nevada.
Does the filing mention any compensatory arrangements for officers?
Yes, the filing lists 'Compensatory Arrangements of Certain Officers' as an item covered by the report.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 regarding BIOREGENX, INC. (BRGX).